Introduction
Every healthcare company's revenue ultimately comes from someone paying for the product or service. In the US, "someone" is a complex web of government programs, commercial insurers, employers, and patients that collectively constitute the payer system. Understanding this system is foundational for healthcare banking because the identity of the payer determines the rate of reimbursement, which flows directly into revenue, margins, and valuation multiples.
The US spends over $4.5 trillion annually on healthcare, roughly 18% of GDP. How that spending flows through the payer system, and which companies capture which portions, is the economic architecture that healthcare bankers must understand.
The Three Payer Categories
US healthcare spending flows through three broad channels, each with distinct economics.
Government Payers (~45% of National Health Expenditure)
Government programs are the largest collective payer in US healthcare. The two dominant programs are:
- [Medicare](/guides/healthcare-investment-banking/medicare-parts-a-through-d): Federal program covering approximately 67 million Americans aged 65+, disabled individuals, and those with end-stage renal disease. Medicare spending exceeds $900 billion annually. Reimbursement rates are set administratively by CMS, not negotiated, and are generally lower than commercial rates
- [Medicaid](/guides/healthcare-investment-banking/medicaid-structure-valuation-impact): Joint federal-state program covering approximately 90 million low-income Americans. Medicaid reimburses at the lowest rates of any major payer, typically 60-80% of Medicare rates. State-by-state variation in eligibility, benefits, and reimbursement creates significant geographic differences in healthcare economics
- Other government: VA/TRICARE (military), CHIP (children), Indian Health Service, federal employee plans, and workers' compensation collectively account for the remainder of government spending
- Centers for Medicare & Medicaid Services (CMS)
The federal agency within the Department of Health and Human Services that administers Medicare, Medicaid, CHIP, and the ACA marketplace. CMS sets reimbursement rates for Medicare, establishes coverage policies, and issues regulations that affect virtually every healthcare provider and payer in the US. CMS decisions on reimbursement methodology, coverage determinations, and quality programs have direct financial impact on healthcare companies and are closely monitored by healthcare bankers.
Commercial Insurance (~35% of NHE)
Commercial insurance includes employer-sponsored health plans (the largest segment), individual market plans (ACA marketplace), and supplemental insurance. Commercial payers reimburse at rates that are negotiated between insurers and providers, typically 150-300% of Medicare rates depending on the service, geography, and the provider's negotiating leverage.
The commercial insurance market is concentrated among a handful of major payers:
| Payer | Covered Lives (Approx.) | Key Characteristics |
|---|---|---|
| UnitedHealth Group | 50M+ | Largest US insurer, also owns Optum (services, PBM, data) |
| Elevance Health (Anthem) | 45M+ | Blue Cross Blue Shield licensee, strong individual market |
| CVS/Aetna | 25M+ | Integrated insurer-pharmacy-PBM model |
| Cigna Group | 18M+ | Strong in employer-sponsored, owns Express Scripts (PBM) |
| Humana | 17M+ | Heavy Medicare Advantage concentration |
| Centene | 25M+ | Largest Medicaid managed care organization |
Out-of-Pocket and Self-Pay (~10% of NHE)
Patient cost-sharing (deductibles, copayments, coinsurance) and uninsured self-pay constitute the remaining ~10% of spending. The trend toward high-deductible health plans has increased the patient-as-payer dynamic, making patient collection efficiency increasingly important for healthcare services companies.
From a banking perspective, self-pay and high patient responsibility create collections risk. Healthcare services companies with high patient responsibility portions face higher bad debt expense and more variable cash flow. This is factored into valuation through adjustments to revenue (net of bad debt) and through EBITDA adjustments that separate ongoing bad debt from one-time write-offs.
Why the Payer System Matters for Healthcare Banking
The payer system's impact on healthcare banking extends far beyond understanding who writes the check:
Revenue quality. Commercial revenue is "higher quality" than government revenue because commercial rates are negotiated (creating upside potential), less subject to unilateral cuts, and more resistant to political risk. Government revenue is more predictable but lower-margin and exposed to administrative rate changes.
Margin determination. Because the same service is reimbursed at dramatically different rates by different payers, the payer mix of a healthcare provider directly determines its margin profile. A physician practice with 70% commercial payer mix operates at fundamentally different economics than one with 70% Medicaid.
M&A strategy. Acquirers evaluate payer mix as a deal criterion. PE firms targeting healthcare services generally prefer companies with high commercial payer mix because of the margin and multiple premium it commands. Strategic acquirers may value geographic payer mix diversification, seeking targets whose payer mix complements their existing portfolio.
The next two articles dive deeper into the two government programs that dominate healthcare spending: Medicare and Medicaid.
Free Interview PDF Guide